Dept. of Clinical… ACL-Leistungsbereich…

Bioanalytical assay development

using liquid chromatography/mass spectrometry (UPLC-MS/MS)

Scope

The development of individual, highly sensitive assays allows quantitative drug and metabolite analyses for numerous applications ranging from cell systems (intra- and extracellular)and small animal models (pharmacokinetic determinations in serum/plasma/blood as well as distribution in tissues) to brain tissues from small animal studies that determine the blood/brain barrier permeability. Our assays, especially the developments for new drug candidates, allow the establishment of pharmacokinetic data (AUC, Cmax, Tmax, T1/2, VD, Cl) from animal studies, which are essential for assessment of pharmacological properties.

Mission

Support of pharmacokinetic (PK) projects in vitro und in vivo

Background

Quantification of drugs and metabolites in samples of biological origin



Most visited


EN